Deborah H. Slee

884 total citations
18 papers, 554 citations indexed

About

Deborah H. Slee is a scholar working on Molecular Biology, Organic Chemistry and Pharmacology. According to data from OpenAlex, Deborah H. Slee has authored 18 papers receiving a total of 554 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 5 papers in Organic Chemistry and 3 papers in Pharmacology. Recurrent topics in Deborah H. Slee's work include Chemical Synthesis and Analysis (3 papers), Receptor Mechanisms and Signaling (3 papers) and Advancements in Transdermal Drug Delivery (2 papers). Deborah H. Slee is often cited by papers focused on Chemical Synthesis and Analysis (3 papers), Receptor Mechanisms and Signaling (3 papers) and Advancements in Transdermal Drug Delivery (2 papers). Deborah H. Slee collaborates with scholars based in United States, Spain and Italy. Deborah H. Slee's co-authors include Vivek Gupta, John A. Muraski, Samir Mitragotri, Aaron C. Anselmo, Michael Zakrewsky, Ming Chen, Ian R. Ollmann, Alla Gustchina, Jukka Kervinen and Chi‐Huey Wong and has published in prestigious journals such as Journal of the American Chemical Society, Journal of Biological Chemistry and Journal of Controlled Release.

In The Last Decade

Deborah H. Slee

16 papers receiving 539 citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Deborah H. Slee 281 162 74 45 40 18 554
Cécile Viodé 420 1.5× 97 0.6× 16 0.2× 25 0.6× 85 2.1× 16 722
Martin Wong 376 1.3× 89 0.5× 24 0.3× 45 1.0× 51 1.3× 20 566
Judi Møss 192 0.7× 58 0.4× 62 0.8× 13 0.3× 17 0.4× 29 539
Hachemi Kadri 303 1.1× 415 2.6× 24 0.3× 24 0.5× 63 1.6× 16 807
Yeoun‐Hee Kim 278 1.0× 64 0.4× 13 0.2× 13 0.3× 51 1.3× 37 742
Duncan S. Holmes 426 1.5× 339 2.1× 11 0.1× 17 0.4× 45 1.1× 39 692
Takuya Kitamura 330 1.2× 136 0.8× 25 0.3× 8 0.2× 27 0.7× 26 600
Vincent H.L. Lee 210 0.7× 37 0.2× 301 4.1× 19 0.4× 20 0.5× 27 743
H. YOSHIOKA 379 1.3× 166 1.0× 17 0.2× 115 2.6× 13 0.3× 68 892
Percy J. Russell 335 1.2× 102 0.6× 19 0.3× 16 0.4× 9 0.2× 30 579

Countries citing papers authored by Deborah H. Slee

Since Specialization
Citations

This map shows the geographic impact of Deborah H. Slee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Deborah H. Slee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Deborah H. Slee more than expected).

Fields of papers citing papers by Deborah H. Slee

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Deborah H. Slee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Deborah H. Slee. The network helps show where Deborah H. Slee may publish in the future.

Co-authorship network of co-authors of Deborah H. Slee

This figure shows the co-authorship network connecting the top 25 collaborators of Deborah H. Slee. A scholar is included among the top collaborators of Deborah H. Slee based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Deborah H. Slee. Deborah H. Slee is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Hegde, Sayee G., Kevin D. Bunker, Deborah H. Slee, et al.. (2025). Discovery of ZN-c5, an Orally Bioavailable Selective Estrogen Receptor Degrader (SERD) with Improved Pharmacokinetics. Journal of Medicinal Chemistry. 68(14). 14740–14755.
2.
Galkin, Anna, Ravikumar Sitapara, Bryan Clemons, et al.. (2022). Inhaled seralutinib exhibits potent efficacy in models of pulmonary arterial hypertension. European Respiratory Journal. 60(6). 2102356–2102356. 49 indexed citations
3.
Cheppudira, Bopaiah P., Thomas H. Garza, Kevin D. Bunker, et al.. (2021). Evaluation of KP‐1199: a novel acetaminophen analog for hemostatic function and antinociceptive effects. Transfusion. 61(S1). S234–S242.
4.
Chen, Ming, Sunny Kumar, Aaron C. Anselmo, et al.. (2014). Topical delivery of Cyclosporine A into the skin using SPACE-peptide. Journal of Controlled Release. 199. 190–197. 42 indexed citations
5.
Chen, Ming, Michael Zakrewsky, Vivek Gupta, et al.. (2014). Topical delivery of siRNA into skin using SPACE-peptide carriers. Journal of Controlled Release. 179. 33–41. 97 indexed citations
6.
Tellew, John E., Marion Lanier, M. N. Moorjani, et al.. (2010). Discovery of NBI-77860/GSK561679, a potent corticotropin-releasing factor (CRF1) receptor antagonist with improved pharmacokinetic properties. Bioorganic & Medicinal Chemistry Letters. 20(24). 7259–7264. 27 indexed citations
7.
Grigoriadis, Dimitri E., Samuel R.J. Hoare, Sandra Lechner, Deborah H. Slee, & John A. Williams. (2008). Drugability of Extracellular Targets: Discovery of Small Molecule Drugs Targeting Allosteric, Functional, and Subunit-Selective Sites on GPCRs and Ion Channels. Neuropsychopharmacology. 34(1). 106–125. 31 indexed citations
8.
Moorjani, M. N., Xiaohu Zhang, Yongsheng Chen, et al.. (2008). 2,6-Diaryl-4-phenacylaminopyrimidines as potent and selective adenosine A2A antagonists with reduced hERG liability. Bioorganic & Medicinal Chemistry Letters. 18(4). 1269–1273. 5 indexed citations
9.
Moorjani, M. N., Zhiyong Luo, Binh G. Vong, et al.. (2008). 2,6-Diaryl-4-acylaminopyrimidines as potent and selective adenosine A2A antagonists with improved solubility and metabolic stability. Bioorganic & Medicinal Chemistry Letters. 18(20). 5402–5405. 9 indexed citations
10.
Mills, Charles D., Marissa Z. McMackin, Randal C. Jaffe, et al.. (2008). Effects of the transient receptor potential vanilloid 1 antagonist A-425619 on body temperature and thermoregulation in the rat. Neuroscience. 156(1). 165–174. 22 indexed citations
11.
Lanier, Marion, Miklós Fehér, Colin J. Loweth, et al.. (2007). Selection, synthesis, and structure–activity relationship of tetrahydropyrido[4,3-d]pyrimidine-2,4-diones as human GnRH receptor antagonists. Bioorganic & Medicinal Chemistry. 15(16). 5590–5603. 33 indexed citations
12.
Nelson, Scott W., Kristen L. Arienti, Frank U. Axe, et al.. (2003). Inhibition of Fructose-1,6-bisphosphatase by a New Class of Allosteric Effectors. Journal of Biological Chemistry. 278(51). 51176–51183. 35 indexed citations
13.
Slee, Deborah H., et al.. (2003). Pyrrolopyrazinedione-Based Inhibitors of Human Hormone-Sensitive Lipase. Journal of Medicinal Chemistry. 46(7). 1120–1122. 30 indexed citations
14.
Slee, Deborah H., Suzanne J. Romano, Jinghua Yu, et al.. (2001). Development of Potent Non-Carbohydrate Imidazole-Based Small Molecule Selectin Inhibitors with Antiinflammatory Activity. Journal of Medicinal Chemistry. 44(13). 2094–2107. 53 indexed citations
15.
Slee, Deborah H., John H. Elder, Ian R. Ollmann, et al.. (1995). Selectivity in the Inhibition of HIV and FIV Protease: Inhibitory and Mechanistic Studies of Pyrrolidine-Containing .alpha.-Keto Amide and Hydroxyethylamine Core Structures. Journal of the American Chemical Society. 117(48). 11867–11878. 88 indexed citations
16.
Adams, Joseph P., Alastair L. Boyes, R. B. LAMONT, et al.. (1994). Synthesis of a novel spirocyclic lactone in a potential route to squalestatin 1. Journal of the Chemical Society Perkin Transactions 1. 1259–1259. 8 indexed citations
17.
Adams, Joseph P., Alastair L. Boyes, Darren J. Mansfield, et al.. (1993). A synthetic approach to squalestatin 1. Journal of the Chemical Society Chemical Communications. 1839–1839. 13 indexed citations
18.
Adams, Joseph P., Alastair L. Boyes, Darren J. Mansfield, et al.. (1993). Synthesis of the bicyclic core structure of squalestatin 1. Journal of the Chemical Society Chemical Communications. 1841–1841. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Cécile Viodé Breakdown of academic impact, for papers by Martin Wong Breakdown of academic impact, for papers by Judi Møss Breakdown of academic impact, for papers by Hachemi Kadri Breakdown of academic impact, for papers by Yeoun‐Hee Kim Breakdown of academic impact, for papers by Duncan S. Holmes Breakdown of academic impact, for papers by Takuya Kitamura Breakdown of academic impact, for papers by Vincent H.L. Lee Breakdown of academic impact, for papers by H. YOSHIOKA Breakdown of academic impact, for papers by Percy J. Russell
Rankless by CCL
2026